Assignee profile:

XBIOTECH, INC.

City:

Vancouver

Country:

Canada

Published Applications:

48

Last publication date:

2023-10-12

Patent Grants:

35

Last grant date:

2026-02-03

Top Inventors for applications by XBIOTECH, INC.

These are the the leading inventors for applications assigned to XBIOTECH, INC.:

Recent patent applications by XBIOTECH, INC.

XBIOTECH, INC. based in Vancouver, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-10-12 ✅ Patent 12,540,176 granted on 2026-02-03
US20230322915A1
Chemistry; metallurgy

True human antibody specific for interleukin 1 alpha

#2 | 2023-09-14 ✅ Patent 12,545,724 granted on 2026-02-10
US20230287104A1
Chemistry; metallurgy

True human antibody specific for interleukin 1 alpha

#3 | 2023-09-14 ✅ Patent 12,552,860 granted on 2026-02-17
US20230287103A1
Chemistry; metallurgy

True human antibody specific for interleukin 1 alpha

#4 | 2023-09-14 ✅ Patent 12,540,177 granted on 2026-02-03
US20230287102A1
Chemistry; metallurgy

True human antibody specific for interleukin 1 alpha

#5 | 2022-11-17 ✅ Patent 12,116,405 granted on 2024-10-15
US20220363750A1
Chemistry; metallurgy

Arthritis treatment

#6 | 2022-08-11 ✅ Patent 11,773,157 granted on 2023-10-03
US20220251175A1
Chemistry; metallurgy

Compositions and methods for treating and preventing infections

#7 | 2020-04-30 ✅ Patent 11,370,831 granted on 2022-06-28
US20200131252A1
Chemistry; metallurgy

Compositions and methods for treating and preventing infections

#8 | 2019-05-02 ✅ Patent 11,932,688 granted on 2024-03-19
US20190127460A1
Chemistry; metallurgy

Treatment for neoplastic diseases

#9 | 2019-05-02 ✅ Patent 10,577,410 granted on 2020-03-03
US20190127449A1
Chemistry; metallurgy

Compositions and methods for treating and preventing infections

#10 | 2018-02-08 ✅ Patent 10,202,449 granted on 2019-02-12
US20180037647A1
Chemistry; metallurgy

Cachexia treatment

#11 | 2017-12-07 ✅ Patent 10,214,581 granted on 2019-02-26
US20170349648A1
Chemistry; metallurgy

Compositions and methods for treating and preventing infections

#12 | 2017-03-23 ✅ Patent 9,988,447 granted on 2018-06-05
US20170081403A1
Chemistry; metallurgy

Treatment of diabetes

#13 | 2016-12-22 ✅ Patent 9,902,769 granted on 2018-02-27
US20160368982A1
Chemistry; metallurgy

Treatment of dermatological pathologies

#14 | 2016-12-15 ✅ Patent 9,670,483 granted on 2017-06-06
US20160362679A1
Chemistry; metallurgy

Immunoglobulin variable region libraries

#15 | 2016-09-29 ✅ Patent 9,486,523 granted on 2016-11-08
US20160279243A1
Human necessities

Compositions and methods for treating and preventing infections

#16 | 2016-03-03 ✅ Patent 9,394,536 granted on 2016-07-19
US20160060619A1
Chemistry; metallurgy

Identifying affinity-matured human antibodies

#17 | 2016-03-03 ✅ Patent 9,453,217 granted on 2016-09-27
US20160060618A1
Chemistry; metallurgy

Identifying affinity-matured human antibodies

#18 | 2016-01-28 ✅ Patent 9,840,558 granted on 2017-12-12
US20160024202A1
Chemistry; metallurgy

Human antibody specific for interleukin-1alpha

#19 | 2015-12-03 ✅ Patent 9,416,172 granted on 2016-08-16
US20150344548A1
Chemistry; metallurgy

Compositions and methods for treating and preventing infections

#20 | 2015-04-02 ✅ Patent 9,181,338 granted on 2015-11-10
US20150094455A1
Chemistry; metallurgy

Human antibody specific for IL-1alpha

#21 | 2014-07-03 ✅ Patent 8,956,831 granted on 2015-02-17
US20140186943A1
Chemistry; metallurgy

Nucleic acids encoding a human monoclonal antibody that specifically binds to IL-1α

#22 | 2014-04-10
US20140099321A1
Chemistry; metallurgy

TREATING VASCULAR DISEASE AND COMPLICATIONS THEREOF

#23 | 2014-03-27 ✅ Patent 9,545,441 granted on 2017-01-17
US20140086933A1
Human necessities

Treatment of diabetes

#24 | 2013-08-01
US20130195877A1
Chemistry; metallurgy

TREATMENT OF CACHEXIA BY TARGETING INTERLEUKIN-1 BETA

#25 | 2013-07-11 ✅ Patent 8,784,817 granted on 2014-07-22
US20130177982A1
Chemistry; metallurgy

Method for killing IL-1 alpha expressing cells

#26 | 2013-07-04 ✅ Patent 8,679,489 granted on 2014-03-25
US20130171728A1
Chemistry; metallurgy

Inhibiting cell migration

#27 | 2013-03-28 ✅ Patent 9,809,649 granted on 2017-11-07
US20130078258A1
Chemistry; metallurgy

Cachexia treatment

#28 | 2013-02-14 ✅ Patent 9,724,409 granted on 2017-08-08
US20130039921A1
Human necessities

Treatment of inflammatory skin disease

#29 | 2013-01-17 ✅ Patent 9,234,030 granted on 2016-01-12
US20130018173A1
Chemistry; metallurgy

Identifying affinity-matured human antibodies

#30 | 2012-11-01 ✅ Patent 8,546,331 granted on 2013-10-01
US20120276110A1
Chemistry; metallurgy

Modulation of pathogenic CD14+/CD16+ monocytes

#31 | 2012-10-04
US20120251548A1
Chemistry; metallurgy

Treatment of Dermatological Pathologies

#32 | 2012-09-13 ✅ Patent 8,865,175 granted on 2014-10-21
US20120231012A1
Physics

Increasing anti-IL-1α antibodies in a subject

#33 | 2012-05-10
US20120114598A1
Human necessities

IL-1alpha immunization induces autoantibodies protective against atherosclerosis

#34 | 2012-04-19
US20120094395A1
Chemistry; metallurgy

Methods for identifying a subject who has developed an anti-antibody response

#35 | 2012-04-19
US20120094301A1
Chemistry; metallurgy

Characterizing an allotypic phenotype of a subject

#36 | 2012-02-23 ✅ Patent 10,294,296 granted on 2019-05-21
US20120045444A1
Chemistry; metallurgy

Treatment for neoplastic diseases

#37 | 2012-01-26
US20120021512A1
Chemistry; metallurgy

Interleukin-1 Alpha Antibodies and Methods of Use

#38 | 2012-01-19 ✅ Patent 8,388,956 granted on 2013-03-05
US20120015433A1
Chemistry; metallurgy

Interleukin-1 alpha antibodies and methods of use

#39 | 2012-01-19 ✅ Patent 8,962,814 granted on 2015-02-24
US20120015384A1
Chemistry; metallurgy

Interleukin-1α antibodies and methods of use

#40 | 2012-01-19 ✅ Patent 8,388,969 granted on 2013-03-05
US20120014971A1
Chemistry; metallurgy

Interleukin-1 alpha antibodies and methods of use

#41 | 2011-12-22
US20110311547A1
Chemistry; metallurgy

Arthritis Treatment

#42 | 2011-03-24
US20110071276A1
Chemistry; metallurgy

Method of modifying a monoclonal antibody

#43 | 2011-03-24
US20110071054A1
Chemistry; metallurgy

Panel of monoclonal antibody containing pharmaceutical compositions

#44 | 2011-03-24
US20110070230A1
Chemistry; metallurgy

Method and devices for identifying and treating a subject who has developed an anti-antibody response

#45 | 2011-03-24
US20110070229A1
Chemistry; metallurgy

Method of selecting a monoclonal antibody for administration

#46 | 2011-01-13
US20110008282A1
Human necessities

IL-1alpha immunization induces autoantibodies protective against atherosclerosis

#47 | 2010-03-18 ✅ Patent 8,242,074 granted on 2012-08-14
US20100068212A1
Chemistry; metallurgy

Modulation of the amount or function of pathogenic CD14+CD16+ monocytes

#48 | 2009-12-03 ✅ Patent 8,034,337 granted on 2011-10-11
US20090298096A1
Chemistry; metallurgy

Interleukin-1α antibodies

Also check out XBIOTECH INC.'s (Vancouver, Canada) applicant profile with 27 patent applications submitted.

AssigneeID:

9298 ⎘